Gout drug colchicine doesn’t lessen COVID-19 severity or stave off risk of death

What happens to our immune systems when we get a booster?
22 November 2021
Aspirin is linked with increased risk of heart failure
23 November 2021

Gout drug colchicine doesn’t lessen COVID-19 severity or stave off risk of death

Colchicine, a cheap anti-inflammatory drug normally used to treat gout, doesn’t lessen COVID-19 severity or stave off the risk of death from the infection in hospital patients, finds a pooled analysis of the available evidence, published in the open access journal RMD Open.

Comments are closed.